Faqrizal Ria Qhabibi is an expert in Nutrition at University of Brawijaya (Indonesia). Faqrizal Ria Qhabibi has authored 17 publications, the most recent in 2026. SLR score: 35 (community average: 125). How the SLR is computed.

LeadR Profile

Faqrizal Ria Qhabibi University of Brawijaya Indonesia
35 ScienceLeadR Reputation 35
Network Map

Nutrition

Subspecialties: Cardiology - Biochemistry - Surgery

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2022 - 2026

Source: PubMed

University of Brawijaya

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 17

Citations

Citations: 107 1st author: 1 Last author: 1 Unique author: 1


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Intravascular lithotripsy versus rotational atherectomy for coronary atherosclerosis calcification: a systematic review and meta-analysis.
PMID 42166042 — mortality, atherosclerosis, atherectomy, lithotripsy
Egypt Heart J20260
Exercise-based cardiac rehabilitation and atherosclerotic plaque regression in ASCVD: Is exercise really a game-changer? A scoping review of controlled trials.
PMID 42160300 — exercise, cardiac rehabilitation, rehabilitation, therapeutics, plaque, atherosclerotic
PLoS One20260
Fragmented QRS complex in athletes' electrocardiogram: physiological adaptation or pathological sign? A scoping review.
PMID 41989620 — drug-related side effects and adverse reactions, prevalence, athletes, adaptation, physiological, cardiomyopathies
Egypt Heart J20260
Unveiling the Group A Streptococcus Vaccine-Based L-Rhamnose from Backbone of Group A Carbohydrate: Current Insight Against Acute Rheumatic Fever to Reduce the Global Burden of Rheumatic Heart Disease.
PMID 39959434 — mortality, heart diseases, streptococcus, vaccines, antibodies, biomedical research, heart, rheumatic fever, vaccination, rheumatic heart disease, morbidity, therapeutics, tissues, rhamnose, carbohydrates, infections
F1000Res20251
Safety and efficacy of PCSK9 inhibitors and effect on coronary plaque phenotype in statin-treated patients following acute coronary syndrome: a systematic review and meta-analysis.
PMID 39365518 — safety, phenotype, acute coronary syndrome, therapeutics, hydroxymethylglutaryl-coa reductase inhibitors
Egypt Heart J20240

LeadR Networks

Main global connection map